Skip to main content
. 2011 Apr 11;2011:0220.
Ref (type) Population Outcome, Interventions Results and statistical analysis Effect size Favours
Adverse effects

RCT
7274 people with hypertension, suitable for treatment with nicardipine, age 18 years and older, mean age 50 years, 60% on current treatment. Other concomitant antihypertensive therapies allowed Pruritus
with nicardipine twice daily (slow release)
with nicardipine 3 times daily
Absolute results not reported

P = 0.043
Effect size not calculated simplified dosing

RCT
7274 people with hypertension, suitable for treatment with nicardipine, age 18 years and older, mean age 50 years, 60% on current treatment. Other concomitant antihypertensive therapies allowed Palpitations
with nicardipine twice daily (slow release)
with nicardipine 3 times daily
Absolute results not reported

P = 0.033
Effect size not calculated simplified dosing

RCT
7274 people with hypertension, suitable for treatment with nicardipine, age 18 years and older, mean age 50 years, 60% on current treatment. Other concomitant antihypertensive therapies allowed People with at least 1 adverse event
with nicardipine twice daily (slow release)
with nicardipine 3 times daily
Absolute results not reported

P = 0.004
Effect size not calculated simplified dosing

RCT
7274 people with hypertension, suitable for treatment with nicardipine, age 18 years and older, mean age 50 years, 60% on current treatment. Other concomitant antihypertensive therapies allowed Hot flushes
with nicardipine twice daily (slow release)
with nicardipine 3 times daily
Absolute results not reported

P = 0.024
Effect size not calculated simplified dosing

RCT
Crossover design
29 men, participants in earlier study, mean age 49 years, on niacin 4 times daily plus lovastatin twice daily plus colestipol twice daily for 1 year, adjusted to maintain target cholesterol 150 mg/dL to 175 mg/dL, high risk of cardiac events (elevated apoprotein B or stenosis or strong family history). Other medication (lovastatin and colestipol) continued as before Flushing
14 people with niacin twice daily
6 people with niacin 4 times daily
Absolute numbers not reported

P <0.005
Effect size not calculated complex dosing